PortfoliosLab logo

Athira Pharma, Inc. (ATHA)

Equity · Currency in USD · Last updated Sep 3, 2022

Company Info

ISINUS04746L1044
CUSIP04746L104
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$3.26
Year Range$2.74 - $16.39
EMA (50)$4.25
EMA (200)$7.72
Average Volume$661.96K
Market Capitalization$127.82M

ATHAShare Price Chart


Chart placeholderClick Calculate to get results

ATHAPerformance

The chart shows the growth of $10,000 invested in Athira Pharma, Inc. in Sep 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,905 for a total return of roughly -80.95%. All prices are adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%20.00%40.00%AprilMayJuneJulyAugustSeptember
-64.61%
-8.26%
ATHA (Athira Pharma, Inc.)
Benchmark (^GSPC)

ATHAReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-3.83%-4.08%
6M-63.94%-10.07%
YTD-74.98%-17.66%
1Y-69.62%-13.26%
5Y-57.15%8.93%
10Y-57.15%8.93%

ATHAMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-20.95%-11.07%47.38%-23.78%-11.76%-66.41%14.10%-2.87%-3.55%
2021-37.75%3.47%-16.59%6.96%1.32%-48.65%-6.15%10.20%-11.43%39.34%3.14%-3.34%
20207.89%-2.17%37.87%37.55%

ATHASharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Athira Pharma, Inc. Sharpe ratio is -0.78. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00AprilMayJuneJulyAugustSeptember
-0.78
-0.64
ATHA (Athira Pharma, Inc.)
Benchmark (^GSPC)

ATHADividend History


Athira Pharma, Inc. doesn't pay dividends

ATHADrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-90.50%
-18.19%
ATHA (Athira Pharma, Inc.)
Benchmark (^GSPC)

ATHAWorst Drawdowns

The table below shows the maximum drawdowns of the Athira Pharma, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Athira Pharma, Inc. is 92.01%, recorded on Jun 24, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-92.01%Dec 24, 2020377Jun 24, 2022
-14.9%Oct 21, 20206Oct 28, 20205Nov 4, 202011
-13.58%Nov 16, 20208Nov 25, 202010Dec 10, 202018
-10.73%Oct 1, 20202Oct 2, 202011Oct 19, 202013
-10%Nov 5, 20202Nov 6, 20205Nov 13, 20207
-6.64%Dec 15, 20201Dec 15, 20202Dec 17, 20203
-6.37%Sep 21, 20204Sep 24, 20204Sep 30, 20208

ATHAVolatility Chart

Current Athira Pharma, Inc. volatility is 55.39%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%500.00%600.00%AprilMayJuneJulyAugustSeptember
55.39%
21.19%
ATHA (Athira Pharma, Inc.)
Benchmark (^GSPC)